
Sally Hyde has no time to recover from the shock of her life after her twin sons were diagnosed with the same type of cancer, almost back to back, with just six months between each diagnosis.
A most cruel quirk of fate that Sally is slowly coming to terms with began with the diagnosis of her 14 year old twin boy, Harry Parnell, with Hodgkin's lymphoma disease.
Advertisement
Just as Harry was rallying round after six months of chemotherapy, now his twin, George, has been struck down with the same illness.
'I've cried but I have to carry on with life,' said Ms Hyde of the diagnosis.
When Harry's twin brother, George, came back one day with a similar lump, his mother instantly knew it was the same illness.
'It's still a massive shock but I feel more prepared this time as I know what to expect,' said Ms Hyde, a cleaner.
The boys are not beaten and instead have converted their fight against cancer into something positive like starting a fundraising drive for Cancer Research.
'I'm proud of my sons with how they cope,' said their mother.
Source: Medindia
When Harry's twin brother, George, came back one day with a similar lump, his mother instantly knew it was the same illness.
Advertisement
'It's still a massive shock but I feel more prepared this time as I know what to expect,' said Ms Hyde, a cleaner.
The boys are not beaten and instead have converted their fight against cancer into something positive like starting a fundraising drive for Cancer Research.
'I'm proud of my sons with how they cope,' said their mother.
Source: Medindia
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News

The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.

Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.

The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.

Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.

Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.